InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Gujrathi Sheila, 董事. Director active across 2 companies, notably Ventyx Biosciences, Inc.. Aggregated, 8 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €288k. Activity tracked since 25 October 2021. The latest transaction was disclosed on 11 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Gujrathi Sheila
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
130,000 股Common StockSEC:0001575202-26-000002:0
3,750 股0Common StockSEC:0001415889-25-017314:0
130,000 股@ US$2.312134.3% 占其流量Common StockSEC:0001415889-24-030180:0
标准退出：2025年3月23日 (T+90)
4,611 股0Common StockSEC:0001415889-24-026386:0
2,500 股0Common StockSEC:0001415889-24-018440:0
2,986 股0Common StockSEC:0001415889-24-006305:0
100,000 股@ US$6.0365.7% 占其流量Common StockSEC:0001209191-23-021887:0
32,897 股0Common StockSEC:0000899243-21-041475:0
8 条申报中的 8 条
About Gujrathi Sheila
Gujrathi Sheila is Administrateur at Ventyx Biosciences, Inc. and Janux Therapeutics, Inc. She has 8 filings in total, and across the sampled recent filings, buys total EUR 288096 and sells total EUR 0, between 2021-10-25 and 2026-03-04. The modal transaction nature is Attribution.
